a public good project by the
Synthesis
Company
of California

© 2026

G Becher | doi.page

0 works0 citations0 h-index

G Becher

Publications by Year

Research Areas

Asthma and respiratory diseases, Advanced Chemical Sensor Technologies, Chronic Obstructive Pulmonary Disease (COPD) Research, Psoriasis: Treatment and Pathogenesis, Inhalation and Respiratory Drug Delivery

Most-Cited Works

→ HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis(2018)169 cited
→ Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis(2022)140 cited
→ Treatment of superficial vascular lesions with the KTP 532-nm laser: experience with 647 patients(2013)71 cited
→ Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens(1998)50 cited
→ Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis(2019)42 cited
→ Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma(2000)42 cited

[Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways].

(1997)

→ Anakinra for palmoplantar pustulosis: results from a randomized, double‐blind, multicentre, two‐staged, adaptive placebo‐controlled trial (APRICOT)*(2021)31 cited

→ Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis(2021)30 cited

→ Palmoplantar pustulosis – a retrospective review of comorbid conditions(2014)26 cited